Matches in Wikidata for { <http://www.wikidata.org/entity/Q99346677> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q99346677 description "article scientifique publié en 2020" @default.
- Q99346677 description "artículu científicu espublizáu en setiembre de 2020" @default.
- Q99346677 description "scientific article published on 07 September 2020" @default.
- Q99346677 description "wetenschappelijk artikel" @default.
- Q99346677 description "наукова стаття, опублікована 7 вересня 2020" @default.
- Q99346677 name "Production of active recombinant human aldehyde oxidase (AOX) in the baculovirus expression vector system (BEVS) and deployment in a pre-clinical fraction-of-control AOX compound exposure assay" @default.
- Q99346677 name "Production of active recombinant human aldehyde oxidase (AOX) in the baculovirus expression vector system (BEVS) and deployment in a pre-clinical fraction-of-control AOX compound exposure assay" @default.
- Q99346677 type Item @default.
- Q99346677 label "Production of active recombinant human aldehyde oxidase (AOX) in the baculovirus expression vector system (BEVS) and deployment in a pre-clinical fraction-of-control AOX compound exposure assay" @default.
- Q99346677 label "Production of active recombinant human aldehyde oxidase (AOX) in the baculovirus expression vector system (BEVS) and deployment in a pre-clinical fraction-of-control AOX compound exposure assay" @default.
- Q99346677 prefLabel "Production of active recombinant human aldehyde oxidase (AOX) in the baculovirus expression vector system (BEVS) and deployment in a pre-clinical fraction-of-control AOX compound exposure assay" @default.
- Q99346677 prefLabel "Production of active recombinant human aldehyde oxidase (AOX) in the baculovirus expression vector system (BEVS) and deployment in a pre-clinical fraction-of-control AOX compound exposure assay" @default.
- Q99346677 P1433 Q99346677-48695364-5EEA-446B-B23C-9C1F8BFDC51C @default.
- Q99346677 P1476 Q99346677-F433DE04-397C-4B7B-A33A-86FC1B6A88A4 @default.
- Q99346677 P2093 Q99346677-32383995-013D-4725-BBFA-82A02C6B1ADB @default.
- Q99346677 P2093 Q99346677-3C9632CD-6480-4942-A1CF-2254FDCD440B @default.
- Q99346677 P2093 Q99346677-5DC8BEE0-1FF1-4A36-A71B-0456A0886984 @default.
- Q99346677 P2093 Q99346677-D8465E36-7D72-4EE0-999D-07C494DE058F @default.
- Q99346677 P2093 Q99346677-F085E886-9F36-47DE-8A49-A3F6A0063F53 @default.
- Q99346677 P2093 Q99346677-F347E8E7-FCD3-489F-8595-E7D25378A81A @default.
- Q99346677 P304 Q99346677-79F20E44-BA75-473B-A56F-78FDEFE939A3 @default.
- Q99346677 P31 Q99346677-DA480447-0D1E-4527-BB34-5E918FB46C19 @default.
- Q99346677 P356 Q99346677-331FB864-246C-441B-9229-3C3BE549D0DC @default.
- Q99346677 P577 Q99346677-C8107B6D-AE13-47B9-9DB9-629385E39CBA @default.
- Q99346677 P698 Q99346677-1FBA216D-53F1-4D86-A737-EF0357147A11 @default.
- Q99346677 P356 J.PEP.2020.105749 @default.
- Q99346677 P698 32911062 @default.
- Q99346677 P1433 Q7251430 @default.
- Q99346677 P1476 "Production of active recombinant human aldehyde oxidase (AOX) in the baculovirus expression vector system (BEVS) and deployment in a pre-clinical fraction-of-control AOX compound exposure assay" @default.
- Q99346677 P2093 "Anthony Carlo" @default.
- Q99346677 P2093 "Ciarán N Cronin" @default.
- Q99346677 P2093 "JianHua Liu" @default.
- Q99346677 P2093 "Nicole Grable" @default.
- Q99346677 P2093 "R Scott Obach" @default.
- Q99346677 P2093 "Timothy J Strelevitz" @default.
- Q99346677 P304 "105749" @default.
- Q99346677 P31 Q13442814 @default.
- Q99346677 P356 "10.1016/J.PEP.2020.105749" @default.
- Q99346677 P577 "2020-09-07T00:00:00Z" @default.
- Q99346677 P698 "32911062" @default.